SCHEMBL9608575

SCHEMBL9608575

COC(=O)c1cccc(-c2nc(=O)c3cc(OC)ccc3o2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 2/20 0.53
THRB P10828 2/20 0.50
ESR1 P03372 1/20 0.50
THRA P10827 1/20 0.50
RXRA P19793 1/20 0.50
PPARG P37231 1/20 0.50
PPARD Q03181 1/20 0.50
PPARA Q07869 1/20 0.50
ESR2 Q92731 1/20 0.50
GPR119 Q8TDV5 1/20 0.49
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
PLAU P00749 2/20 0.47
PLAT P00750 2/20 0.47
PLG P00747 1/20 0.47
ALDH1A1 P00352 6/20 0.46
HPGD P15428 6/20 0.46
KDM4E B2RXH2 5/20 0.46
HSD17B10 Q99714 5/20 0.46
TP53 P04637 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9608577 0.88 GPR119 (0.52) VDRGPR119ALDH1A1HPGDKDM4E
SCHEMBL9609338 0.87 MAPT (0.57) VDRTHRBESR1THRARXRA
SCHEMBL12754449 0.87 GPR119 (0.53) VDRGPR119ALDH1A1HPGDKDM4E
SCHEMBL9609236 0.84 GPR119 (0.47) VDRPPARGPPARAGPR119ALDH1A1
SCHEMBL9609212 0.78 MAPT (0.57) VDRTHRBESR1THRARXRA
SCHEMBL31247990 0.77 KDM4E (0.74) GPR119ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL28605620 0.77 KDM4E (0.74) GPR119ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL9616651 0.77 HPGD (0.66) ALDH1A1HPGDKDM4EHSD17B10TP53
SCHEMBL17254744 0.77 ALDH1A1 (0.48) THRBMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL2110839 0.75 GPR119 (0.56) VDRTHRBESR1THRARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957140-B2 Triazine derivative, ultraviolet absorber, and resin composition FUJIFILM CORPORATION (JP) 2015-02-17 US disclosed
US-8957140-B2 Triazine derivative, ultraviolet absorber, and resin composition FUJIFILM CORPORATION (JP) 2015-02-17 US disclosed
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2012-05-31 US disclosed
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION C1R, RPSA, H1-2 VDR 513/4885THRB 497/4885ESR1 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.